Prospecto: information for the user
Fentanilo Aurovitas Spain 25 micrograms/h transdermal patches EFG
Read this prospect carefully before starting to use this medicine, as it contains important information for you.
1. What isFentanilo Aurovitas Spainand for what it is used
2. What you need to know before starting to useFentanilo Aurovitas Spain
3. How to useFentanilo Aurovitas Spain
4. Possible adverse effects
5. Storage ofFentanilo Aurovitas Spain
6. Contents of the package and additional information
This medicine is called Fentanilo Aurovitas Spain.
The patches help to relieve very strong and long-lasting pain:
Fentanilo Aurovitas Spain contains a medicine called fentanilo. It belongs to a group of strong pain-relieving medicines called opioids.
No use Fentanilo Aurovitas Spain:
Do not use this medication if you or your child is in any of the above circumstances. If you are unsure, consult your doctor or pharmacist before using fentanyl.
Warnings and Precautions
Fentanyl may have life-threatening adverse effects in people who are not regularly using prescribed opioids.
Fentanilo Aurovitas Spainis a medication that could put the lives of children at risk,even if the patches have already been used. Note that an adhesive patch (used or unused) could attract the attention of a child, and if it sticks to the child's skin or if the child puts it in their mouth, the result could be fatal.
Keep this medication in a safe and protected place, where others cannot access it, see section 5 for more information.
If the patch sticks to another person
The patch should only be used on the skin of the people for whom the doctor has prescribed it. There have been some cases where a patch has accidentally stuck to another family member by close physical contact or sharing the same bed with the person wearing the patch. If the patch accidentally sticks to another person (particularly a child), the medication from the patch can pass through the skin of the other person and may cause serious adverse effects, such as difficulty breathing, with slow or weak breathing that can be fatal. In the event that the patch sticks to the skin of another person, it should be immediately removed and the person should seek medical attention.
Be especially careful with Fentanilo Aurovitas Spain
Consult your doctor or pharmacist beforeusing this medicationif you are in any of the following circumstances. Your doctor will have to monitor you more closely:
If you meet any of the above conditions (or if you are unsure), consult your doctor or pharmacist before using fentanyl.
While using the patch, report to your doctor if you have breathing problems while sleeping.
Opioids like fentanyl can cause sleep-related breathing disorders such as sleep apnea (pauses in breathing while sleeping) and sleep-related hypoxemia (low oxygen levels in the blood). Talk to your doctor if you, your partner, or caregiver observe any of the following symptoms:
Your doctor may decide to modify the dose.
While using the patch, report to your doctor if you notice a change in the pain you feel.If you feel:
Do not change the dose on your own. Your doctor may decide to modify the dose or change the treatment.
Adverse effects and Fentanilo Aurovitas Spain
See section 4 for the complete list of possible adverse effects.
When wearing the patch, do not expose it to direct heat, such as heating pads, electric blankets, hot water bottles, hot tubs, or heat lamps or tanning beds. Do not take the sun or long hot baths and do not use saunas or hot tubs. If you do, it may increase the amount of medication released from the patch.
Long-term use and tolerance
This medication contains fentanyl, an opioid. Repeated use of opioid painkillers can make the medication less effective (your body becomes accustomed to it, known as pharmacological tolerance). It is also possible that you will become more sensitive to pain when using the fentanyl transdermal patch. This is known as hyperalgesia. Increasing the dose of the patches may continue to reduce pain for a while, but it may also be harmful. If you notice that the medication is losing its effectiveness, consult your doctor. Your doctor will decide whether it is better to increase the dose or gradually reduce the use of the fentanyl transdermal patch.
Dependence and addiction
The repeated use of fentanyl can also cause dependence, abuse, and addiction, which could lead to a potentially fatal overdose. The risk of these adverse effects may be higher with a higher dose and longer use. Dependence or addiction may cause you to feel a lack of control over the amount of medication you should use or how often you should use it. You may feel the need to continue using the medication even if it no longer helps to relieve pain.
The risk of dependence or addiction varies from person to person. The risk of becoming dependent or addicted to the fentanyl transdermal patch may be higher if:
If you notice any of the following symptoms while using the fentanyl transdermal patch, it could be a sign of dependence or addiction.
If you notice any of these signs, consult your doctor to determine the best course of treatment for you, when it is appropriate to stop the medication, and how to do it safely.
Withdrawal symptoms from stopping Fentanilo Aurovitas Spain
Do not stop using this medication abruptly. Withdrawal symptoms such as restlessness, difficulty sleeping, irritability, agitation, anxiety, feeling your heartbeat (palpitations), increased blood pressure, feeling or being sick, diarrhea, loss of appetite, tremors, chills, or sweating may occur. If you want to stop using this medication, talk to your doctor first. Your doctor will advise you on how to do it, usually the dose will be gradually reduced to minimize unpleasant withdrawal symptoms.
Other medications and Fentanilo Aurovitas Spain
Inform your doctor or pharmacist if you are using, have used recently, or may need to use any other medication.Here, this includes over-the-counter medications and herbal remedies. You should also inform your pharmacist that you are using fentanyl if you buy any medication at the pharmacy.
Your doctor will know which medications can be taken safely with fentanyl. You may need to be closely monitored if you are taking any of the types of medications listed below or if you stop taking any of the types of medications listed, as this may affect the dose of fentanyl you need.
Especially, inform your doctor or pharmacist if you are taking:
Using fentanyl with antidepressants
The risk of adverse effects increases if you are taking medications such as certain antidepressants. Fentanyl may interact with these medications, and you may experience changes in your mental state such as agitation, seeing, feeling, hearing, or smelling things that are not there (hallucinations), and other effects such as changes in blood pressure, rapid heartbeat, high body temperature, hyperactive reflexes, lack of coordination, muscle stiffness, nausea, vomiting, and diarrhea (which may be signs of a serotonin syndrome). If you are taking them together, your doctor may want to closely monitor you to detect these side effects, especially when starting treatment or when changing the dose of the medication.
Using with central nervous system depressants, including alcohol and some narcotics
The use of fentanyl with sedatives such as benzodiazepines or related medications increases the risk of drowsiness, difficulty breathing (respiratory depression), coma, and can be life-threatening. For this reason, concurrent use should only be considered when other treatment options are not possible.
However, if your doctor prescribes fentanyl along with sedatives, your doctor should limit the dose and duration of concurrent treatment.
Inform your doctor of all sedatives you are taking, and follow your doctor's dose recommendations strictly. It may be helpful to inform friends or family members about the signs and symptoms mentioned above. Contact your doctor if you experience these symptoms.
Do not drink alcohol while using fentanyl, unless you have talked to your doctor first.
Use in athletes
Inform athletes that this medication contains a component that may result in a positive analytical result for doping control.
Surgeries
If you think you will receive anesthesia, inform your doctor or dentist that you are using fentanyl.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, or if you think you may be pregnant, consult your doctor or pharmacist before using this medication.
Fentanyl should not be used during pregnancy, unless you have talked to your doctor.
Fentanyl should not be usedduring labor, as the medication may affect the newborn's breathing.
Prolonged use of fentanyl during pregnancy may cause withdrawal symptoms (such as loud crying, feeling restless, convulsions, poor feeding, and diarrhea) in your newborn, which can be potentially fatal if not recognized and treated. Talk to your doctor immediately if you think your newborn may have withdrawal symptoms.
Do not use fentanyl if you are breastfeeding. Do not breastfeed for 3 days after removing the fentanyl patch. This is because the medication may pass into breast milk.
Driving and using machines
Fentanylmay affect your ability to drive and use machines or tools, as it may cause drowsiness or dizziness. If this is the case, do not drive or use tools or machines. Do not drive while using this medication until you know how it affects you.
Talk to your doctor or pharmacist if you have doubts about whether it is safe for you to drive while using this medication.
Before starting treatment and regularly during it, your doctor will also explain what you can expect from the use of the fentanyl transdermal patch, when and for how long you should use it, when you should contact your doctor and when you should discontinue use (see also section 2, "Withdrawal syndrome when interrupting treatment with Fentanilo Aurovitas Spain").
Your doctor will decide what dose of fentanyl is most suitable for you, taking into account the intensity of your pain, your general condition and the type of pain treatment you have been receiving up to this point.
How to apply and change the patches
Apply the patch onChange the patch on |
MondayThursday |
TuesdayFriday |
WednesdaySaturday |
ThursdaySunday |
FridayMonday |
SaturdayTuesday |
SundayWednesday |
Where to apply the patch
Adults
Children
Adults and children:
Do not apply the patch to
How to apply the patch
Step 1: Prepare the skin
Step 2: Open the package
Step 3: Peel and press
Step 4: Dispose of the patch
Step 5: Wash your hands
More information about the use of Fentanilo Aurovitas Spain
Activities during the use of the patches
How long do the patches take to act?
For how long will you have to use the patches?
If the pain worsens
If you use too many patches or a patch with the wrong dose
If you have applied too many patches or a patch with the wrong dose, remove them and contact your doctor immediately or go to the hospital.
You can also call the Toxicology Information Service, phone 91 562 04 20, indicating the medication and the amount ingested or applied.
The signs of overdose include breathing difficulties or weak breathing, fatigue, extreme drowsiness, inability to think clearly or walk or speak normally, and dizziness or confusion. An overdose can also cause a brain disorder known as toxic leukoencephalopathy.
If you forget to change the patch
If the patch comes off
If you want to stop using the patches
If you have any other questions about the use of this product, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everyone will experience them.
If you, or your partner or caregiver, observe any of the following signs in the person wearing the patch, remove the patch and call a doctor or go immediately to the nearest hospital. You may need urgent medical treatment.
Follow the previous recommendations and have the person wearing the patch move and speak as much as possible. In very rare cases, these breathing difficulties can compromise life or even be fatal, especially in people who have not used strong opioid analgesics (such as fentanyl or morphine) before. (Rare, may affect up to 1 in 100 patients).
They can all be signs of a severe allergic reaction. (Frequency cannot be estimated from available data).
The following side effects have also been reportedside effects
Very common (may affect more than 1 in 10 patients)
Common (may affect up to 1 in 10 patients)
Rare (may affect up to 1 in 100 patients)
Rare (may affect up to 1 in 1000 patients)
Unknown frequency (cannot be estimated from available data)
You may notice rashes, redness, or a mild itching sensation on the skin where the patch is applied. It is usually mild and disappears after removing the patch. If not, or if the patch irritates your skin a lot, inform your doctor.
The repeated use of patches may make the medication less effective (you become accustomed to it or become more sensitive to pain) or may cause dependence.
If you switch from another analgesic to fentanyl or stop using fentanyl abruptly, you may experience withdrawal symptoms, such as dizziness, feeling sick, diarrhea, anxiety, or tremors. Inform your doctor if you notice any of these effects.
Cases of newborn babies experiencing withdrawal symptoms after their mothers used fentanily for a prolonged period during pregnancy have also been reported.
Reporting of side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this leaflet. You can also report them directly through the Spanish System for the Pharmacovigilance of Medicines for Human Use: www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Where to Store the Patches
Keep all patches (used and unused) out of sight and reach of children.
How Long Can Fentanilo Aurovitas Spain Be Stored
Do not use this medication after the expiration date that appears on the box and on the package. The expiration date is the last day of the month indicated. If the patches are expired, take them to the pharmacy.
Storage Conditions
Do not store at a temperature above 86°F (30°C).
Store this medication in a safe and protected place, to which other people cannot access. This medication can cause severe harm and even be fatal to people who use it accidentally or intentionally when not prescribed.
How to Dispose of Used or Unused Patches
Accidental exposure of another person to used and unused patches, especially in children, can result in a fatal outcome.
Used patches should be folded firmly in half, so that the adhesive side of the patch adheres to itself. Then, they should be safely discarded by placing them in the original package and storing them out of sight and reach of other people, especially children, until they are safely disposed of.
Medications should not be thrown away through drains or in the trash. Deposit the containers and medications you no longer need at the SIGRE collection point at the pharmacy.Ask your pharmacist how to dispose of containers and medications you no longer need. This will help protect the environment.
Composition ofFentanilo Aurovitas Spain
Adhesive layer: acrylic adhesive layer.
Support layer: polypropylene layer, blue printing ink.
Release layer: polyethylene terephthalate layer (siliconized).
Appearance of the product and content of the container
Fentanilo Aurovitas Spainis a transparent transdermal patch, with an adhesive support to stick to the skin. The transdermal patches have a blue print that indicates the dose.
Fentanilo Aurovitas Spain is availablein containers of3, 4, 5, 8, 10, 16 or 20transdermal patches.
Only some sizes of containers may be commercially marketed.
Marketing authorization holder and responsible manufacturer
Marketing authorization holder
Aurovitas Spain, S.A.U.
Avda. de Burgos, 16-D
28036 Madrid
Spain
Responsible manufacturer
Luye Pharma AG
Am Windfeld 35
83714 Miesbach
Germany
This medicine is authorized in the member states of the European Economic Area with the following names:
GermanyFentanyl Actavis 25 Mikrogramm/h transdermal plaster
SpainFentanilo Aurovitas Spain 25 micrograms/h transdermal patches EFG
NetherlandsFentanyl Aurobindo 25 μg/ hour, patch for transdermal use
PortugalFentanilo Aurovitas
Last review date of this leaflet:March 2024
Detailed information about this medicine is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS) (http://www.aemps.gob.es/)
Have questions about this medication or your symptoms? Connect with a licensed doctor for guidance and personalized care.